April 22, 2011
A big step in your medical freedom
There's some good news in the medical freedom front. You may know that I like to call the FDA the Fraud and Deception Administration. That's partly because the FDA has attacked company after company for attaching truthful information to nutritional products. There has been horrible fallout from these actions.
The FDA actually prosecuted companies for making truthful claims about folic acid. Science proved that folic acid could prevent neural tube defects in newborns. But since the manufacturers of the nutrient could tell people about this, thousands of children came into the world with defects. Had their moms known about folic acid, they could have prevented these defects.
Under blistering heat for causing thousands of birth defects unnecessarily, the FDA backed down in humiliation. Still the agency continues to attack truthful claims. Most of these never make the news. Perhaps it's because they aren't as horrific as birth defects. But heart, vascular, and brain challenges, and so many other health issues are crucial for good health. Still, the FDA insists that a claim attached to a supplement converts that natural product into "an unapproved drug."
Now, there's a bill before the Congress called The Free Speech About Science (FSAS) Act. Representative Jason Chaffetz of Utah has entered HR1364. He designed this bill to protect your access to scientific information. It amends the current FDA law to allow the flow of legitimate scientific and educational information attached to supplements. It still permits the FDA and FTC the right to take action against false and misleading information. This is appropriate. The FDA should have never had any ability to take action against truthful statements. To most people, that's a blatant violation of the First Amendment.
Could you detect a deadly poison in a healthy-looking meal?
The answer may shock you…
Click Here To Learn More
This is a small but important step in medical freedom. In my opinion, the FDA acts more as the enforcing arm of Big Pharma, than a protector of the people. Currently, Big Pharma grabs billions in blood money profits from its false and fraudulent studies. And the FDA recalls or stops these poisons only after the drug companies have made their "killing." But if you were to make a truthful statement about a non-patented natural substance, you'll get fined and possibly jailed. The only way for Pharma to stay in business with inferior and dangerous products is to maintain its monopoly on disease maintenance. You can help bring down the monopoly and the unholy Big Pharma alliance with the FDA!
Right now, the bill is in the House Committee on Energy and Commerce. If you have any Representatives who serve on this committee, please urge them to take up the bill. Otherwise, it'll likely never get out. To find out who serves on this committee and how to contact them, please visit this website: http://www.govtrack.us/congress/committee.xpd?id=HSIF
PS. As you may know, I was the first to bring you the good news of a far kinder and gentler, and far more effective chemotherapy for cancer called IPT, or insulin potentiation therapy. In this treatment, the doctor gives the hormone insulin ahead of chemo drugs. It makes the cancer far more susceptible to the drugs, so that you need far less chemo. This, naturally, spares you from most of the horrors of chemotherapy.
I will be attending the IPT conference coming up on May 13 and 14 in Ft. Lauderdale, Florida. There are a lot of subscribers in south Florida, and cancer is a worry in the older population. It will be held at The Westin Diplomat Resort & Spa in Hollywood, Florida (for hotel reservations, call 954-602-6000).
The general public is invited, though the society charges $149 to cover expenses. You can call 512-342-8181 for more information.If you are local to the area, and especially if you are faced with a cancer challenge, please consider coming! Many of my talented physician friends from around the country will be present, either presenting their work, or simply attending.